These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36435700)

  • 1. The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model.
    Hoffman K; Brownell Z; Doyle WJ; Ochoa-Repáraz J
    J Autoimmun; 2023 May; 137():102957. PubMed ID: 36435700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
    Glenn JD; Mowry EM
    J Interferon Cytokine Res; 2016 Jun; 36(6):347-57. PubMed ID: 27145057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
    Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
    Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.
    Dopkins N; Nagarkatti PS; Nagarkatti M
    Immunology; 2018 Jun; 154(2):178-185. PubMed ID: 29392733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of microbiome metabolites on immune regulation and autoimmunity.
    Haase S; Haghikia A; Wilck N; Müller DN; Linker RA
    Immunology; 2018 Jun; 154(2):230-238. PubMed ID: 29637999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by
    Erturk-Hasdemir D; Ochoa-Repáraz J; Kasper DL; Kasper LH
    Front Immunol; 2021; 12():662807. PubMed ID: 34025663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feeding the gut microbiome: impact on multiple sclerosis.
    Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
    Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
    Montgomery TL; Künstner A; Kennedy JJ; Fang Q; Asarian L; Culp-Hill R; D'Alessandro A; Teuscher C; Busch H; Krementsov DN
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27516-27527. PubMed ID: 33077601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
    Yadav SK; Ito K; Dhib-Jalbut S
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota.
    van den Hoogen WJ; Laman JD; 't Hart BA
    Front Immunol; 2017; 8():1081. PubMed ID: 28928747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome and the risk factors in central nervous system autoimmunity.
    Ochoa-Repáraz J; Kasper LH
    FEBS Lett; 2014 Nov; 588(22):4214-22. PubMed ID: 25286403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
    Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
    Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis.
    Saadh MJ; Ahmed HM; Alani ZK; Al Zuhairi RAH; Almarhoon ZM; Ahmad H; Ubaid M; Alwan NH
    Neuromolecular Med; 2024 Apr; 26(1):14. PubMed ID: 38630350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical update on the significance of the gut microbiota in systemic autoimmunity.
    Rosser EC; Mauri C
    J Autoimmun; 2016 Nov; 74():85-93. PubMed ID: 27481556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut Microbiome and Multiple Sclerosis.
    Ochoa-Repáraz J; Kirby TO; Kasper LH
    Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 29311123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strength Exercise Confers Protection in Central Nervous System Autoimmunity by Altering the Gut Microbiota.
    Chen H; Shen L; Liu Y; Ma X; Long L; Ma X; Ma L; Chen Z; Lin X; Si L; Chen X
    Front Immunol; 2021; 12():628629. PubMed ID: 33796102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.
    Stanisavljević S; Dinić M; Jevtić B; Đedović N; Momčilović M; Đokić J; Golić N; Mostarica Stojković M; Miljković Đ
    Front Immunol; 2018; 9():942. PubMed ID: 29770137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome and multiple sclerosis: New insights and perspective.
    Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
    Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis.
    Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Guaza C
    Biochem Pharmacol; 2018 Nov; 157():51-66. PubMed ID: 30171835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.